This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maternal serum concentrations of soluble endoglin and soluble Vascular Endothelial Growth Factor Receptor 2 may predict the severity of villous hypoplasia in severe early-onset fetal growth restriction. (September 2017)
Record Type:
Journal Article
Title:
Maternal serum concentrations of soluble endoglin and soluble Vascular Endothelial Growth Factor Receptor 2 may predict the severity of villous hypoplasia in severe early-onset fetal growth restriction. (September 2017)
Main Title:
Maternal serum concentrations of soluble endoglin and soluble Vascular Endothelial Growth Factor Receptor 2 may predict the severity of villous hypoplasia in severe early-onset fetal growth restriction